Pharmaceutical-Bio Industry''s First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwired) -- 01/20/15 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the first quarter of 2015 gathers steam, the is projected to launch $3.9 billion worth of North American projects through the end of March. A healthy cash injection of that magnitude is cause for jubilation, or at the least, cautious optimism.
Within this article: Details on the industry''s North American kickoffs in first-quarter 2015, including major projects from AstraZeneca (NYSE:AZN), Gilead Sciences (NASDAQ:GILD) and the U.S. Army Public Health Command.
For details, , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info''s quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what''s happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
William Ploch
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.01.2015 - 05:15 Uhr
Sprache: Deutsch
News-ID 1331146
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SUGAR LAND, TX
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 218 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharmaceutical-Bio Industry''s First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
